Mirae Asset Global Investments Co., Ltd. Sanofi Transaction History

Mirae Asset Global Investments Co., Ltd.

$37.3 Billion
Q1 2025

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Sanofi stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 24,131 shares of SNY stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,131

Previous 10,773 124.0%

Holding current value

$1.23 Million

Previous $519,000 157.8%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 24, 2025	BUY	$48.15 - $59.42 $643,187 - $793,732	13,358 Added 124.0%	24,131 $1.34 Million
Q4 2024 Jan 27, 2025	SELL	$45.89 - $57.31 $43,503 - $54,329	-948 Reduced 8.09%	10,773 $519,000
Q3 2024 Oct 23, 2024	BUY	$48.54 - $58.53 $101,934 - $122,913	2,100 Added 21.83%	11,721 $675,000
Q2 2024 Jul 30, 2024	SELL	$45.39 - $50.36 $1.82 Million - $2.01 Million	-39,997 Reduced 80.61%	9,621 $466,000
Q1 2024 May 01, 2024	BUY	$45.75 - $52.48 $149,511 - $171,504	3,268 Added 7.05%	49,618 $2.41 Million
Q4 2023 Jan 24, 2024	BUY	$43.13 - $54.79 $106,272 - $135,002	2,464 Added 5.61%	46,350 $2.3 Million
Q3 2023 Oct 26, 2023	SELL	$50.95 - $55.2 $731,642 - $792,672	-14,360 Reduced 24.65%	43,886 $2.35 Million
Q2 2023 Aug 10, 2023	BUY	$50.45 - $57.18 $634,862 - $719,553	12,584 Added 27.56%	58,246 $3.14 Million
Q1 2023 May 04, 2023	BUY	$45.86 - $54.45 $96,948 - $115,107	2,114 Added 4.85%	45,662 $2.48 Million
Q4 2022 Feb 09, 2023	BUY	$38.86 - $48.55 $124,235 - $155,214	3,197 Added 7.92%	43,548 $2.11 Million
Q3 2022 Nov 10, 2022	BUY	$37.22 - $100.5 $1.5 Million - $4.06 Million	40,351 New	40,351 $1.53 Million
Q2 2022 Jul 26, 2022	SELL	$48.99 - $57.46 $649,852 - $762,206	-13,265 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$48.48 - $53.65 $274,784 - $304,088	-5,668 Reduced 29.94%	13,265 $681,000
Q4 2021 Feb 08, 2022	BUY	$47.07 - $52.35 $328,972 - $365,874	6,989 Added 58.51%	18,933 $949,000
Q3 2021 Nov 15, 2021	BUY	$47.89 - $53.12 $82,897 - $91,950	1,731 Added 16.95%	11,944 $576,000
Q2 2021 Aug 11, 2021	BUY	$49.36 - $54.25 $4,195 - $4,611	85 Added 0.84%	10,213 $538,000
Q1 2021 May 13, 2021	SELL	$45.46 - $50.51 $26,366 - $29,295	-580 Reduced 5.42%	10,128 $501,000
Q4 2020 Feb 10, 2021	SELL	$45.3 - $51.62 $2.44 Million - $2.78 Million	-53,848 Reduced 83.41%	10,708 $520,000
Q3 2020 Nov 12, 2020	BUY	$49.47 - $53.77 $39,130 - $42,532	791 Added 1.24%	64,556 $3.24 Million
Q2 2020 Aug 11, 2020	SELL	$42.91 - $52.5 $120,920 - $147,945	-2,818 Reduced 4.23%	63,765 $3.26 Million
Q1 2020 May 12, 2020	BUY	$38.02 - $51.66 $228,690 - $310,734	6,015 Added 9.93%	66,583 $2.91 Million
Q4 2019 Feb 12, 2020	BUY	$44.25 - $50.86 $73,233 - $84,173	1,655 Added 2.81%	60,568 $3.04 Million
Q3 2019 Nov 12, 2019	SELL	$40.34 - $46.64 $548,866 - $634,583	-13,606 Reduced 18.76%	58,913 $2.73 Million
Q2 2019 Aug 13, 2019	BUY	$40.43 - $44.3 $2.93 Million - $3.21 Million	72,519 New	72,519 $3.14 Million
Q1 2019 May 13, 2019	SELL	$40.83 - $45.43 $2.57 Million - $2.86 Million	-62,863 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$41.48 - $45.59 $1.88 Million - $2.07 Million	45,315 Added 258.23%	62,863 $2.73 Million
Q3 2018 Nov 13, 2018	SELL	$40.0 - $44.84 $90,840 - $101,831	-2,271 Reduced 11.46%	17,548 $784,000
Q2 2018 Aug 14, 2018	SELL	$37.63 - $41.22 $269,656 - $295,382	-7,166 Reduced 26.56%	19,819 $793,000
Q1 2018 May 10, 2018	SELL	$38.98 - $45.76 $597,017 - $700,860	-15,316 Reduced 36.21%	26,985 $1.08 Million
Q4 2017 Feb 12, 2018	BUY	$42.86 - $50.61 $312,835 - $369,402	7,299 Added 20.85%	42,301 $1.82 Million
Q3 2017 Nov 08, 2017	SELL	$47.04 - $50.34 $33,257 - $35,590	-707 Reduced 1.98%	35,002 $1.74 Million
Q2 2017 Aug 14, 2017	BUY	N/A	35,709	35,709 $1.71 Million

Others Institutions Holding SNY

# of Institutions

856

Shares Held

269M

Call Options Held

1.48M

Put Options Held

1.34M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $128B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Sanofi Transaction History